Hemostemix Stock Probability of Future OTC Stock Price Finishing Over 0.0625
| HMTXF Stock | USD 0.06 0.0004 0.64% |
Hemostemix |
Hemostemix Target Price Odds to finish over 0.0625
The tendency of Hemostemix OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.06 | 90 days | 0.06 | about 76.57 |
Based on a normal probability distribution, the odds of Hemostemix to move above the current price in 90 days from now is about 76.57 (This Hemostemix probability density function shows the probability of Hemostemix OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Hemostemix has a beta of 0.4. This usually indicates as returns on the market go up, Hemostemix average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hemostemix will be expected to be much smaller as well. Additionally Hemostemix has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hemostemix Price Density |
| Price |
Predictive Modules for Hemostemix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hemostemix. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hemostemix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hemostemix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hemostemix is not an exception. The market had few large corrections towards the Hemostemix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hemostemix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hemostemix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 0.40 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.05 |
Hemostemix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hemostemix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hemostemix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hemostemix generated a negative expected return over the last 90 days | |
| Hemostemix has some characteristics of a very speculative penny stock | |
| Hemostemix has high historical volatility and very poor performance | |
| Hemostemix has a very high chance of going through financial distress in the upcoming years | |
| Hemostemix has accumulated 1.48 M in total debt. Hemostemix has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Hemostemix until it has trouble settling it off, either with new capital or with free cash flow. So, Hemostemix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hemostemix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hemostemix to invest in growth at high rates of return. When we think about Hemostemix's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemostemix has accumulated about 649.32 K in cash with (3.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 12.0% of the company shares are held by company insiders |
Hemostemix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hemostemix OTC Stock often depends not only on the future outlook of the current and potential Hemostemix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hemostemix's indicators that are reflective of the short sentiment are summarized in the table below.
Hemostemix Technical Analysis
Hemostemix's future price can be derived by breaking down and analyzing its technical indicators over time. Hemostemix OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hemostemix. In general, you should focus on analyzing Hemostemix OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Hemostemix Predictive Forecast Models
Hemostemix's time-series forecasting models is one of many Hemostemix's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hemostemix's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Hemostemix
Checking the ongoing alerts about Hemostemix for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hemostemix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hemostemix generated a negative expected return over the last 90 days | |
| Hemostemix has some characteristics of a very speculative penny stock | |
| Hemostemix has high historical volatility and very poor performance | |
| Hemostemix has a very high chance of going through financial distress in the upcoming years | |
| Hemostemix has accumulated 1.48 M in total debt. Hemostemix has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Hemostemix until it has trouble settling it off, either with new capital or with free cash flow. So, Hemostemix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hemostemix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hemostemix to invest in growth at high rates of return. When we think about Hemostemix's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemostemix has accumulated about 649.32 K in cash with (3.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 12.0% of the company shares are held by company insiders |
Other Information on Investing in Hemostemix OTC Stock
Hemostemix financial ratios help investors to determine whether Hemostemix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemostemix with respect to the benefits of owning Hemostemix security.